You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 20, 2025

Details for Patent: 10,842,768


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,842,768 protect, and when does it expire?

Patent 10,842,768 protects VASCEPA and is included in one NDA.

This patent has seventy-three patent family members in twenty-seven countries.

Summary for Patent: 10,842,768
Title:Compositions and methods for lowering triglycerides
Abstract: In various embodiments, the present invention provides compositions and methods for treating and/or preventing cardiovascular-related diseases in subject in need thereof.
Inventor(s): Osterloh; Ian (Kent, GB), Wicker; Pierre (Mystic, CT), Braeckman; Rene (Richboro, PA), Soni; Paresh (Mystic, CT), Manku; Mehar (Birmingham, GB)
Assignee: Amarin Pharmaceuticals Ireland Limited (Dublin, IE)
Application Number:16/364,720
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,842,768

Introduction to Patents and the USPTO

The United States Patent and Trademark Office (USPTO) is the agency responsible for granting U.S. patents and registering trademarks. Patents are crucial for protecting intellectual property and encouraging innovation. To delve into the specifics of United States Patent 10,842,768, it is essential to understand the broader context of patent law and the process of patenting.

Overview of Patent 10,842,768

Title and Purpose: United States Patent 10,842,768, titled "Compositions and methods for lowering triglycerides," pertains to medical and biochemical innovations aimed at reducing triglyceride levels in the body. This patent involves specific compositions and methods for treating conditions associated with high triglyceride levels.

Inventorship and Ownership

Determining True Inventors: In the U.S., patent law stipulates that only the "true and only" inventors of patentable subject matter are entitled to a patent. This involves a two-step process: the conception of the idea and the reduction of the idea to practice. Correctly identifying inventors is crucial for the enforceability of the patent[2].

Patent Claims

Importance of Patent Claims: Patent claims are the heart of a patent, defining the scope of the invention and what is protected by the patent. The scope of a patent is often a subject of debate, with metrics such as independent claim length and independent claim count used to measure it. Narrower claims are generally associated with a higher probability of grant and a shorter examination process[3].

Independent Claims:

For Patent 10,842,768, the independent claims outline the specific compositions and methods that are patented. These claims must be clear, concise, and novel to be granted. Here, the claims would include detailed descriptions of the biochemical processes and the specific fatty acid methyl esters analyzed to lower triglycerides.

Dependent Claims:

Dependent claims build upon the independent claims, providing additional details or variations of the invention. These claims help to further define the scope of the patent and ensure that all aspects of the invention are protected.

Patent Scope and Breadth

Measuring Patent Scope: The scope of a patent is critical in determining its validity and enforceability. Metrics such as independent claim length and count are used to assess the breadth of the patent. For Patent 10,842,768, the scope would be measured by the specificity and novelty of the claims related to the compositions and methods for lowering triglycerides[3].

Technology Area and Classification

Classification Under WIPO: The USPTO classifies patents based on the World Intellectual Property Organization (WIPO) classification system, which includes 35 technical fields. Patent 10,842,768 would fall under the category of chemistry or biochemistry, given its focus on biochemical processes and fatty acid analysis[1].

Examination Process

Grant and Examination: The examination process for patents involves a thorough review to ensure that the claims are novel, nonobvious, and useful. For Patent 10,842,768, the examination would have included a review of the biochemical methods, the analysis of fatty acid methyl esters, and the efficacy of the compositions in lowering triglycerides. Narrower claims, as mentioned earlier, are often associated with a shorter and more successful examination process[3].

Prior Art and Novelty

Prior Art Considerations: Prior art refers to existing knowledge and inventions in the public domain. For a patent to be granted, the invention must be novel and nonobvious over the prior art. The patent application for 10,842,768 would have been scrutinized to ensure that the compositions and methods presented were not already known or obvious from existing literature and patents.

Legal Status and Enforcement

Active Status: As of the current date, Patent 10,842,768 is listed as active, indicating that it is still in force and its claims are enforceable. This status is subject to maintenance payments and other legal requirements to keep the patent active[4].

Practical Applications and Impact

Medical Implications: The compositions and methods described in Patent 10,842,768 have significant medical implications, particularly in the treatment of conditions associated with high triglyceride levels. This innovation could lead to new therapeutic approaches and improved patient outcomes.

Economic and Innovation Impact

Innovation and R&D: Patents like 10,842,768 drive innovation by protecting intellectual property and encouraging further research and development. The increase in patenting activity, especially in fields like biochemistry and electrical engineering, reflects the growing importance of intellectual property protection in driving technological advancements[1].

Conclusion

Understanding the scope and claims of United States Patent 10,842,768 involves a detailed analysis of the patent's claims, the technological area it belongs to, and the legal and practical implications of the patent. This patent, focused on compositions and methods for lowering triglycerides, highlights the importance of clear and specific claims, the role of prior art, and the impact on medical and biochemical innovation.

Key Takeaways

  • Patent Claims: Clear and specific claims are crucial for defining the scope of the patent.
  • Inventorship: Correctly identifying the true and only inventors is essential for the enforceability of the patent.
  • Technology Area: The patent falls under the category of chemistry or biochemistry.
  • Examination Process: Narrower claims are associated with a higher probability of grant and a shorter examination process.
  • Legal Status: The patent is currently active and enforceable.
  • Impact: The patent has significant medical implications and drives innovation in the field.

FAQs

Q: What is the main focus of United States Patent 10,842,768? A: The main focus is on compositions and methods for lowering triglycerides.

Q: How are patent claims measured for scope? A: Metrics such as independent claim length and independent claim count are used to measure the scope of a patent.

Q: Why is correct inventorship important? A: Correct inventorship is crucial for the enforceability of the patent and to ensure that the true inventors are recognized.

Q: Under which WIPO classification does this patent fall? A: The patent falls under the category of chemistry or biochemistry.

Q: What is the current legal status of Patent 10,842,768? A: The patent is currently active and enforceable.

Sources

  1. Invention: U.S. and Comparative Global Trends - National Science Foundation.
  2. Determining Inventorship for US Patent Applications - Oregon State University.
  3. Patent Claims and Patent Scope - SSRN.
  4. US10842768B2 - Compositions and methods for lowering triglycerides - Google Patents.
  5. U.S. Patent and Trademark Office (USPTO) - USAGov.

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,842,768

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Amarin Pharms VASCEPA icosapent ethyl CAPSULE;ORAL 202057-001 Jul 26, 2012 AB RX Yes Yes ⤷  Try for Free ⤷  Try for Free USE OF VASCEPA TO LOWER TRIGLYCERIDES AND LDL-C IN AN ADULT PATIENT WITH ELEVATED TRIGLYCERIDE (TG) LEVELS (ABOUT 200 MG/DL TO LESS THAN ABOUT 500 MG/DL) AND ON STATIN THERAPY ⤷  Try for Free
Amarin Pharms VASCEPA icosapent ethyl CAPSULE;ORAL 202057-002 Feb 16, 2017 AB RX Yes No ⤷  Try for Free ⤷  Try for Free USE OF VASCEPA TO LOWER TRIGLYCERIDES AND LDL-C IN AN ADULT PATIENT WITH ELEVATED TRIGLYCERIDE (TG) LEVELS (ABOUT 200 MG/DL TO LESS THAN ABOUT 500 MG/DL) AND ON STATIN THERAPY ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,842,768

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 2443246 ⤷  Try for Free 301137 Netherlands ⤷  Try for Free
European Patent Office 2443246 ⤷  Try for Free LUC00226 Luxembourg ⤷  Try for Free
European Patent Office 2443246 ⤷  Try for Free PA2021522 Lithuania ⤷  Try for Free
European Patent Office 2443246 ⤷  Try for Free 2021C/538 Belgium ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.